Introduction: Mild cognitive impairment (MCI) is a cognitive disturbance in which intensity is not enough to be classified as dementia and does not affect significantly the functioning or activities of daily living. The MCI has a progression rate to Alzheimer-type dementia (ATD) related to different factors.

Aim: To evaluate the association between the presence of psychological and behavioural symptoms (PBS) with progression to ATD en MCI subjects.

Patients And Methods: We evaluated 318 patients with MCI assessed in a Dementia Unit of Catalonia between 1998 to 2002 who were followed five years after the MCI diagnosis. We determined the PBS presence, those classified as affective, behavioural and psychotic symptoms. We also assessed sociodemographic aspects and the ApoE genotype.

Results: The mean age was 74 +/- 7.87 years-old, 56.7% presented PBS, with affective (53%), behavioural (32.2%) and psychotic symptoms (14.8%). In the study, 32.1% progressed to ATD. We found association between the presence of PBS and the progression to ATD (OR = 2.77; 95% CI = 1.66-4.63), specifically with behavioural and psychotic symptoms. The ApoE epsilon4 allele showed association with the progression to ATD (OR = 1.81; 95% CI = 1.11-2.94). The logistic regression model showed a significant association between the PBS and the epsilon4 allele with the progression to ATD.

Conclusions: The PBS presence in MCI patients is associated with ATD progression with or without ApoE epsilon4 allele.

Download full-text PDF

Source

Publication Analysis

Top Keywords

progression atd
12
psychotic symptoms
12
epsilon4 allele
12
behavioural symptoms
8
alzheimer-type dementia
8
mild cognitive
8
association presence
8
pbs progression
8
pbs presence
8
behavioural psychotic
8

Similar Publications

Background: COVID-19 emerged in December 2019 and rapidly became a global pandemic. It has since been associated with the progression of various endocrine disorders, including thyroid disease. The long-term effects of this interplay have yet to be explored.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline, memory impairment, and behavioral alterations. The N-methyl-D-aspartate (NMDA) receptor has emerged as a promising target for AD pharmacotherapy due to its role in the disease's pathogenesis. This study leverages advanced computational methods to screen 80 active constituents of Withania somnifera (Ashwagandha), a traditional herb known for its neuroprotective effects, against the NMDA receptor, using FDA-approved Ifenprodil as a reference.

View Article and Find Full Text PDF
Article Synopsis
  • Robust definitions of time-to-event endpoints are essential for evaluating treatment effects and the clinical value of interventions in trials.
  • The Head and Neck Cancer International Group reviewed 92 phase 3 trials from 2008 to 2021 focused on curative treatments for mucosal head and neck squamous cell carcinoma.
  • The study found significant variability in how core endpoint components, like overall survival and progression-free survival, were reported, emphasizing the need for standardization and collaboration among stakeholders for clearer endpoint reporting.
View Article and Find Full Text PDF

Background: Myopia, characterized by excessive axial elongation of the eyeball, increases risks of having sight-threatening diseases and impose a financial burden to healthcare system. Although myopic control interventions showed their effectiveness in slowing progression, the efficacy varies between individuals and does not completely halt progression. The study aims to investigate the efficacy of combining 0.

View Article and Find Full Text PDF

Objective: Antithyroid drug (ATD)-induced agranulocytosis (TIA) is the most serious adverse effect during ATD treatment of Graves' disease (GD). Previously, the gene was reported to be associated with TIA. protein is an important ligand for the NKG2D protein, which is encoded by the gene and read-through transcription.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!